Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/EJE-08-0021
European Journal of Endocrinology, Vol 159, Issue 2, 187-196
Copyright © 2008 by European Society of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
EJE-08-0021v1
159/2/187    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Lazáry, A.
Right arrow Articles by Lakatos, P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lazáry, A.
Right arrow Articles by Lakatos, P.

CLINICAL STUDIES

Single nucleotide polymorphisms in new candidate genes are associated with bone mineral density and fracture risk

Áron Lazáry1,2,*, János P Kósa1,*, Bálint Tóbiás1, Judit Lazáry3, Bernadett Balla1, Krisztián Bácsi1, István Takács1, Zsolt Nagy1, Tibor Mezo1, Gábor Speer1 and Péter Lakatos1

1 1st Department of Internal Medicine, Semmelweis University, Koranyi S. u. 2/a., Budapest H-1083, Hungary2 National Center for Spinal Disorders, Buda Health Center, Budapest H-1126, Hungary3 Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest H-1089, Hungary

(Correspondence should be addressed to Á Lazáry; Email: lazaron{at}bel1.sote.hu)

Objective: Osteoporosis (OP) is a multifactorial disease with high heritability but its exact genetic background is still poorly understood. We examined the effect of 24 single nucleotide polymorphisms (SNPs) located in five genes – alkaline phosphatase, matrix metalloproteinase-2, tissue inhibitor of metalloproteases-2 (TIMP2), fibroblast growth factor receptor-1 (FGFR1), and fatty acid-binding protein-3 (FABP3) – previously not associated with OP.

Design: We performed a genotype–phenotype association study at a university hospital.

Methods: A total of 360 Hungarian postmenopausal women were involved in the study. Bone mineral density (BMD) was determined at spine, hip, and distal radius. Genomic DNA was extracted from venous blood samples and a high-throughput genotyping method based on single-based primer extension was applied for allelic discrimination. Robust statistical tools were utilized for multiplex data analysis.

Results: SNP rs6996321 in FGFR1 was significantly related to spine BMD (P=0.002) and rs10914367 in FABP3 was associated with hip BMD (P=0.028). Non-vertebral fracture risk was significantly increased in carriers of ‘A’ allele of rs9900972 in TIMP2 (odds ratio=2.06, P=0.0187). We could also identify validated gene–gene interactions significantly affecting BMD and fracture risk.

Conclusions: We identified two previously unreported SNPs in FGFR1 and FABP3 associated with BMD and a third SNP in TIMP2 related to risk for non-vertebral osteoporotic fractures. This is the first report about the association between these allelic variants and the phenotypes of postmenopausal OP. Further studies need to clarify the role of these genes and their polymorphisms in the process of bone loss.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 European Society of Endocrinology.